{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:35:44Z","timestamp":1792812944994,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41429-024-00713-7","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:01:49Z","timestamp":1710136909000},"page":"331-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-1356","authenticated-orcid":false,"given":"Aoi","family":"Kimishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Honsho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsei","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wasuwanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sota","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-3340","authenticated-orcid":false,"given":"Hidehito","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-9169","authenticated-orcid":false,"given":"Yukihiro","family":"Asami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"713_CR1","unstructured":"Antibiotic Resistance Threats in the United States. Department of Health and Human Services, CDC; 2019, www.cdc.gov\/drugresistance\/Biggest-Threats.html."},{"key":"713_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"AR Collaborators","year":"2022","unstructured":"Collaborators AR. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"713_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009;325:1089\u201393.","journal-title":"Science"},{"key":"713_CR4","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2147\/IDR.S180283","volume":"11","author":"T Liu","year":"2018","unstructured":"Liu T, Zhang Y, Wan Q. bacteremia among liver transplant recipients. Infect Drug Resist. 2018;11:2345\u201356.","journal-title":"Infect Drug Resist"},{"key":"713_CR5","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1128\/AEM.02866-07","volume":"74","author":"SO Stoitsova","year":"2008","unstructured":"Stoitsova SO, Braun Y, Ullrich MS, Weingart H. Characterization of the RND-type multidrug efflux pump MexAB-OprM of the plant pathogen Pseudomonas syringae. Appl Environ Microbiol. 2008;74:3387\u201393.","journal-title":"Appl Environ Microbiol"},{"key":"713_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39659-4","volume":"9","author":"R Ferrer-Espada","year":"2019","unstructured":"Ferrer-Espada R, Shahrour H, Pitts B, Stewart PS, Sa\u0301nchez- Go\u0301mez S, Marti\u0301nez-de-Tejada G. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains. Sci Rep. 2019;9:3452.","journal-title":"Sci Rep"},{"key":"713_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41429-023-00607-0","volume":"76","author":"A Kimishima","year":"2023","unstructured":"Kimishima A, Sakai K, Honsho M, Wasuwanich P, Matsui H, Watanabe Y, et al. An efflux pump deletion mutant enabling the discovery of a macrolide as an overlooked anti-P. aeruginosa active compound. J Antibiot. 2023;76:301\u20133.","journal-title":"J Antibiot"},{"key":"713_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41429-023-00628-9","volume":"76","author":"A Kimishima","year":"2023","unstructured":"Kimishima A, Sakai K, Honsho M, Matsui H, Wasuwanich P, Watanabe Y, et al. A combination strategy of a semisynthetic macrolide, 5-O-mycaminosyltylonolide with polymyxin B nonapeptide for multi-drug resistance P. aeruginosa. J Antibiot. 2023;76:499\u2013501.","journal-title":"J Antibiot"},{"key":"713_CR9","unstructured":"Phan LT, Qui YL, Or YS, Vo NH, Jian T, Hou Y, Busuyek M. 23-O-Substituted 5-O-Mycaminosyltylonide Derivatives. 2003, Patent WO03089446A2."},{"key":"713_CR10","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1021\/jm9904598","volume":"42","author":"TE Renau","year":"1999","unstructured":"Renau TE, L\u00e9ger R, Flamme EM, Sangalang J, She MW, Yen R, et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem. 1999;42:4928\u201331.","journal-title":"J Med Chem"},{"key":"713_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10156-008-0623-2","volume":"14","author":"Y Niki","year":"2008","unstructured":"Niki Y, Hanaki H, Yagisawa M, Kohno S, Aoki N, Watanabe A, et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J Infect Chemother. 2008;14:279\u201390.","journal-title":"J Infect Chemother"},{"key":"713_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s10156-012-0509-1","volume":"18","author":"Y Takesue","year":"2012","unstructured":"Takesue Y, Watanabe A, Hanaki H, Kusachi S, Matsumoto T, Iwamoto A, et al. Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. J Infect Chemother. 2012;18:816\u201326.","journal-title":"J Infect Chemother"},{"key":"713_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jiac.2015.05.014","volume":"21","author":"K Ishikawa","year":"2015","unstructured":"Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, et al. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J Infect Chemother. 2015;21:623\u201333.","journal-title":"J Infect Chemother"},{"key":"713_CR14","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 32nd ed. 2022. Available from: https:\/\/clsi.org."},{"key":"713_CR15","doi-asserted-by":"crossref","unstructured":"Leber AL, et al. Clinical Microbiology Procedures Handbook. 1-3, 4th ed. Washinngton, DC: ASM Press. American Society for Microbiology; 2016.","DOI":"10.1128\/9781555818814"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00713-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T23:03:14Z","timestamp":1714431794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1038\/s41429-024-00713-7","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}